Definitive Contract 75F40123C00133

Award Date 9/13/23
Potential Completion Date 9/28/26
Potential Value $442K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The American Academy of Ophthalmology, Inc. was awarded a $393,716 firm fixed price definitive contract by the United States Department of Health and Human Services Food and Drug Administration to conduct A STUDY IN LEVERAGING THE REAL-WORLD DATA FROM THE AMERICAN ACADEMY OF OPHTHALMOLOGY'S IRIS REGISTRY TO EVALUATE THE USE AND IMPACT OF APPROVED MEDICAL DEVICES AND SOFTWARE ALGORITHMS. The place of performance will be in Silver Spring, Maryland, with work beginning on September 23, 2022 and...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price purchase order contract to Optores GMBH, a for-profit limited liability company manufacturer, for the delivery of a High-Speed Fourier-Domain Mode-Locked Laser (NG-FDML-1060-7508B-FA) for an Ophthalmic Optical Coherence Tomography (OCT) System. The original solicitation was not set aside and was posted on May 24, 2019 with a due date of June 5, 2019. The potential value of the contract is...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,275,361.26 definitive cost-no-fee contract to Alliance Nctn Foundation, a non-profit organization and foundation, to conduct the "Integrating Clinical Trials and Real World Endpoints Data (ICAREDATA) Data Capture and Standardization Study". This contract, with a performance period ending on September 29, 2024, is part of the FDA's broader efforts to advance regulatory science and support public...
<p>The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $275,033 firm fixed price purchase order contract to QSA Global, Inc. to provide three Open Vision DX C-arm digital real time X-ray imaging systems with wireless monitors. The place of performance for this one-month contract is Derwood, Maryland, with a period of performance starting on September 13, 2022 and ending on October 13, 2022. No applicable subcontractors were identified.</p>
The Department of Health and Human Services Food and Drug Administration awarded a $350,000 definitive cost-no-fee contract to Elligo Health Research, Inc. to support the agency's Broad Agency Announcement seeking proposals to extend the value of common data model harmonization in generating clinical evidence from real world data sufficient to support regulatory use. The small disadvantaged business will perform work at locations in Silver Spring, Maryland under the contract addressing the FDA's...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $4,122,028.80 delivery order contract to Koniag Management Solutions LLC to obtain eight scientific contract professionals to support the research program of the FDA's Center for Drug Evaluation and Research, Office of Biotechnology Products. The contract is for a base period of performance from June 24, 2022 to June 26, 2025 in Silver Spring, Maryland and utilizes a labor hours pricing structure.
The Department of Health and Human Services, Food and Drug Administration awarded a $5,504,791.00 firm fixed-price contract to Aetion, Inc. for real-world evidence research and development to rapidly assess the safety and effectiveness of COVID-19 countermeasures in inpatient settings. This contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science, which supports ongoing regulatory science research and innovation. The contract does not have a set-aside...
<p>The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $704,702.17 firm fixed-price purchase order contract to Conceptant Inc., a for-profit organization, for a project titled &quot;VISUALIZING INTERCONNECTED PROJECTS.&quot; The contract was awarded on September 14, 2018 and has a completion date of March 14, 2021. The contract does not have a set-aside designation.</p>
The Department of Health and Human Services Food and Drug Administration awarded a $43,377.15 firm fixed-price purchase order to 3T Business Group LLC Construction Division for a resonant scanner and bright field arm for the Sutter MoM microscope. This contract has a period of performance from September 26, 2023 through November 21, 2023 at the place of performance in Silver Spring, Maryland. The solicitation requested quotes by September 18, 2023 for a resonant scanner to be used in the...
This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The $28,209,345.33 contract supports the FDA's &quot;ADVANCING REGULATORY SCIENCE FOR CLINICAL EVIDENCE GENERATION, ASSESSMENT, AND ANALYTICS&quot; initiative, providing a range of data analytics, AI/ML, healthcare IT, and management consulting services...

The Department of Health and Human Services Food and Drug Administration awarded a $441,597 firm fixed price definitive contract to the Collaborative Community On Ophthalmic Imaging Foundation. The contract was awarded under Broad Agency Announcement FY23 FDA BAA for Advanced Research and Development of Regulatory Science to support enhancing visual health equity via novel, real-world underserved population health data sets utilizing ophthalmic imaging and artificial intelligence. The place of performance is Silver Spring, Maryland. The period of performance is from September 13, 2023 through September 28, 2026. There is no set-aside designation. The solicitation sought proposals addressing modernizing product development and evaluation, strengthening post-market surveillance and labeling, or invigorating public health preparedness and response.

Generated 12/29/23, 2:40 PM